ロード中...
Determining eligibility for antiretroviral therapy in resource-limited settings using total lymphocyte counts, hemoglobin and body mass index
BACKGROUND: CD4+ T lymphocyte (CD4) cell count testing is the standard method for determining eligibility for antiretroviral therapy (ART), but is not widely available in sub-Saharan Africa. Total lymphocyte counts (TLCs) have not proven sufficiently accurate in identifying subjects with low CD4 cou...
保存先:
主要な著者: | , , , , , , , , |
---|---|
フォーマット: | Artigo |
言語: | Inglês |
出版事項: |
BioMed Central
2007
|
主題: | |
オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1796890/ https://ncbi.nlm.nih.gov/pubmed/17233896 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1742-6405-4-1 |
タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|